OBJECTIVE -Early identification of subjects at high risk for diabetes is essential, and random HbA 1c (A1C) may be more practical than fasting plasma glucose (FPG). The predictive value of A1C, in comparison to FPG, is evaluated for 6-year incident diabetes.
RESEARCH DESIGN AND METHODS -From the French cohort study Data from anEpidemiological Study on the Insulin Resistance Syndrome (DESIR), 1,383 men and 1,437 women, aged 30 -65 years, were volunteers for a routine health check-up. Incident diabetes was defined by FPG Ն7.0 mmol/l or treatment by antidiabetic drugs. Multivariate logistic regression models were used to predict diabetes at 6 years. Receiver operating characteristic curves compared the predictive values of A1C and FPG.RESULTS -At 6 years, 30 women (2.1%) and 60 men (4.3%) had developed diabetes. Diabetes risk increased exponentially with A1C in both sexes (P Ͻ 0.001). After stratifying on FPG, A1C predicted diabetes only in subjects with impaired fasting glucose (IFG) (FPG Ն6.10 mmol/l): the odds ratio (95% CI) for a 1% increase in A1C was 7.20 (3.00 -17.00). In these subjects, an A1C of 5.9% gave an optimal sensitivity of 64% and specificity of 77% to predict diabetes.CONCLUSIONS -A1C predicted diabetes, even though the diagnosis of diabetes was based on FPG, but it was less sensitive and specific than FPG. It could be used as a test if fasting blood sampling was not available or in association with FPG. In subjects with IFG, A1C is better than glucose to evaluate diabetes risk, and it could be used to select subjects for intensive early intervention.
Diabetes Care 29:1619 -1625, 2006T he prevalence of type 2 diabetes is increasing worldwide, and it is projected that the number of adults with diabetes will double between 2000 and 2030 (1). This means a large burden for the health care system. Recent clinical trials have demonstrated that lifestyle (2-4) or pharmaceutical (4 -6) interventions in individuals with impaired glucose tolerance (IGT) can delay or prevent diabetes; thus high-risk subjects should be identified for early intensive lifestyle counseling or even pharmaceutical treatment (7).Fasting and 2-h plasma glucose after an oral glucose tolerance test (OGTT) are currently used to identify subjects at high risk of diabetes (8): those with impaired fasting glucose (IFG) and IGT. However, the OGTT is not common in clinical practice, because it is time consuming, costly, and less reproducible (9) than measurement of fasting plasma glucose (FPG).HbA 1c (A1C), an indirect measure of mean blood glucose over the previous 2-3 months, is correlated with FPG and 2-h plasma glucose (10 -12). A1C is more reproducible than FPG (13) and withinsubject coefficients of variation are 1.7 and 5.7%, respectively (14). Moreover, measurement of A1C does not require that the subject is fasting. The use of A1C could better integrate chronic hyperglycemia than FPG.Few studies have investigated predicting diabetes using A1C and none in a Caucasian population. Moreover, previous investigations were in populations a...